Web11 Oct 2024 · Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized... WebScott A. Smith is the chief executive officer of Viatris and a member of the company’s board of directors. He is leading the execution of Phase 2 of the company’s strategic plan designed to guide Viatris into a period of …

Viatris Announces Appointments of Scott A. Smith and Elisha W.

Web27 Feb 2024 · Robert J. Coury, Executive Chairman of Viatris said, "As we now prepare to enter into Phase 2 of our evolution for 2024 and beyond, we believe Scott Smith is the … Web27 Feb 2024 · Viatris Inc., a global healthcare company, as it enters Phase 2 of its previously announced strategic plan in 2024, Scott A. Smith has been appointed to lead the … herf stock

Scott Smith - Chief Executive Officer - Viatris ZoomInfo

Web27 Feb 2024 · Generic drugmaker Viatris on Monday named Scott Smith as its new CEO beginning April 1, shaking up its leadership as it advances into a new phase of an ongoing … Web20 Feb 2024 · Viatris Inc. announced that as it prepares to enter phase 2 of its previously announced strategic plan in 2024, Scott A. Smith has been appointed by its Board of … WebScott A. Smith is the chief executive officer of Viatris and a member of the company’s board of directors. He is leading the execution of Phase 2 of the company’s strategic plan designed to guide Viatris into a period of renewed growth. Smith is a deeply knowledgeable senior global biotechnology and pharmaceutical executive with more than ... matt morsia weight